Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-22

Clinical Trial Update: Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the safety and potential efficacy of umbilical cord-derived mesenchymal stem cells for Alzheimer's disease in Phase 1/2. The study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord-derived Mesenchymal Stem Cells (UC-MSC) (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: UNKNOWN